Akanda Corp. (NASDAQ:AKAN – Get Free Report) was the recipient of a large decrease in short interest in December. As of December 31st, there was short interest totaling 151,372 shares, a decrease of 83.2% from the December 15th total of 903,214 shares. Approximately 41.6% of the shares of the company are short sold. Based on an average trading volume of 4,767,598 shares, the short-interest ratio is currently 0.0 days. Based on an average trading volume of 4,767,598 shares, the short-interest ratio is currently 0.0 days. Approximately 41.6% of the shares of the company are short sold.
Analyst Ratings Changes
AKAN has been the topic of several recent research reports. Weiss Ratings began coverage on Akanda in a report on Wednesday, October 15th. They set a “sell (e+)” rating on the stock. Wall Street Zen upgraded shares of Akanda to a “sell” rating in a research note on Saturday, October 18th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has an average rating of “Sell”.
View Our Latest Analysis on AKAN
Akanda Trading Down 25.1%
About Akanda
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
See Also
- Five stocks we like better than Akanda
- “Ominous day” coming to stocks…
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Punch these codes into your ordinary brokerage account
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Trump just signed it
Receive News & Ratings for Akanda Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akanda and related companies with MarketBeat.com's FREE daily email newsletter.
